Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Mar;61(3):264-72.
doi: 10.1001/archpsyc.61.3.264.

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial

Affiliations
Clinical Trial

Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial

Kathleen M Carroll et al. Arch Gen Psychiatry. 2004 Mar.

Abstract

Context: Disulfiram has emerged as a promising treatment for cocaine dependence, but it has not yet been evaluated in general populations of cocaine users.

Objectives: To compare the effectiveness of disulfiram therapy with that of a placebo condition in reducing cocaine use and to compare the effectiveness of 2 active behavioral therapies-cognitive behavior therapy (CBT) and interpersonal psychotherapy (IPT)-in reducing cocaine use.

Design: Randomized, placebo-controlled, double-masked (for medication condition), factorial (2 x 2) trial with 4 treatment conditions: disulfiram plus CBT, disulfiram plus IPT, placebo plus CBT, and placebo plus IPT.

Setting: A community-based outpatient substance abuse treatment program.

Patients: A total of 121 individuals meeting the criteria for current cocaine dependence.

Interventions: Patients received either disulfiram (250 mg/d) or placebo in identical capsules. Medication compliance was monitored using a riboflavin marker procedure. Both behavioral therapies (CBT and IPT) were manual guided and were delivered in individual sessions for 12 weeks.

Main outcome measures: Random regression analyses of self-reported frequency of cocaine use and results of urine toxicology screens.

Results: Participants assigned to disulfiram reduced their cocaine use significantly more than those assigned to placebo, and those assigned to CBT reduced their cocaine use significantly more than those assigned to IPT (P<.01 for both). Findings were consistent across all study samples (eg, intention to treat, treatment initiators, and treatment completers). Benefits of disulfiram use and CBT were most pronounced for participants who were not alcohol dependent at baseline or who fully abstained from drinking alcohol during treatment. Adverse effects experienced by participants who received disulfiram were mild and were not considerably different from those experienced by participants who received placebo.

Conclusions: Disulfiram and CBT are effective therapies for general populations of cocaine-dependent individuals. Disulfiram seems to exert a direct effect on cocaine use rather than through reducing concurrent alcohol use.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diagram of participant recruitment, retention, and follow-up.
Figure 2
Figure 2
Frequency of cocaine use by treatment week. Effects are estimates from random regression analyses. CBT indicates cognitive behavior therapy; IPT, interpersonal psychotherapy.

Similar articles

Cited by

References

    1. National Institute on Drug Abuse. Principles of Drug Abuse Treatment: A Research-Based Guide. Bethesda, Md: National Institute on Drug Abuse; 2000.
    1. Carroll KM, Rounsaville BJ, Bryant KJ. Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance. J Stud Alcohol. 1993;54:199–208. - PubMed
    1. Brady KT, Sonne S, Randall CL, Adinoff B, Malcolm RJ. Features of cocaine dependence with concurrent alcohol dependence. Drug Alcohol Depend. 1995;39:69–71. - PubMed
    1. Heil SH, Badger GJ, Higgins ST. Alcohol dependence among cocaine dependent outpatients: demographics, drug use, treatment outcome and other characteristics. J Stud Alcohol. 2001;62:14–22. - PubMed
    1. McCance-Katz EF, Price LH, Kosten TR, Jatlow PM. Cocaethylene: pharmacology, physiology, and behavioral effects in humans. J Pharmacol Exp Ther. 1995;274:215–223. - PubMed

Publication types